Onconetix (ONCO) Receivables - Other (2021 - 2026)
Onconetix (ONCO) posted quarterly Receivables - Other of -$50000.0 for Q1 2026, down 552.2% year-over-year from $11057.0 in Q1 2025, and down 597.66% quarter-over-quarter from $10047.0 in Q4 2025.
Onconetix (ONCO) Receivables - Other (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Receivables - Other for 6 consecutive years, with -$50000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 552.2% year-over-year to -$50000.0; the TTM figure through Dec 2025 stood at $10047.0 (down 75.98% YoY), while the FY2025 annual figure was $300000.0, up 617.1% from the prior year.
- Receivables - Other eased to -$50000.0 in Q1 2026 per ONCO's latest filing, from $10047.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $522000.0 in Q3 2023 and bottomed at -$50000.0 in Q1 2026.
- Historically, Receivables - Other has averaged $121316.7 across 5 years, with a median of $35425.0 in 2022.
- Annual changes were most pronounced in 2023 — Receivables - Other soared 1391.43% — and 2026, when it tumbled 552.2%.
- Onconetix's Receivables - Other stood at $35850.0 in 2022, then soared by 343.51% to $159000.0 in 2023, then plunged by 73.69% to $41835.0 in 2024, then slumped by 75.98% to $10047.0 in 2025, then slumped by 597.66% to -$50000.0 in 2026.
- Business Quant data shows ONCO's Receivables - Other at -$50000.0 in Q1 2026, $10047.0 in Q4 2025, and $10046.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Onconetix | 1.45 Mn | -4.49 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,172.00 |
| Jun 30, 2026 | 6,172.00 |
| Mar 31, 2026 | -50,000.00 |
| Mar 31, 2026 | -50,000.00 |
| Dec 31, 2025 | 10,047.00 |
| Dec 31, 2025 | 10,047.00 |
| Sep 30, 2025 | 10,046.00 |
| Sep 30, 2025 | 10,046.00 |
| Jun 30, 2025 | 12,599.00 |
| Jun 30, 2025 | 12,599.00 |
| Mar 31, 2025 | 11,057.00 |
| Mar 31, 2025 | 11,057.00 |
| Dec 31, 2024 | 41,835.00 |
| Dec 31, 2024 | 41,835.00 |
| Sep 30, 2024 | 363,000.00 |
| Sep 30, 2024 | 363,000.00 |
| Jun 30, 2024 | 363,000.00 |
| Jun 30, 2024 | 363,000.00 |
| Dec 31, 2023 | 159,000.00 |
| Dec 31, 2023 | 159,000.00 |